Detalhe da pesquisa
1.
Nitroxoline shows antimyeloma activity by targeting the TRIM25/p53 axle.
Anticancer Drugs
; 28(4): 376-383, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28301380
2.
Targeting the oncogenic transcription factor c-Maf for the treatment of multiple myeloma.
Cancer Lett
; 543: 215791, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700821
3.
Interferon-stimulated gene 15 induces cancer cell death by suppressing the NF-κB signaling pathway.
Oncotarget
; 7(43): 70143-70151, 2016 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27659523
4.
An inhibitor of cholesterol absorption displays anti-myeloma activity by targeting the JAK2-STAT3 signaling pathway.
Oncotarget
; 7(46): 75539-75550, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27705908
5.
A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway.
Oncotarget
; 7(8): 9296-308, 2016 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-26814430
6.
Correction: A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway.
Oncotarget
; 7(49): 81972, 2016 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28082727